Concord Medical Services Holdings Limited

NYSE:CCM

Sector

🏥 Health Care

Industries

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Telehealth

Location

China

Market Cap

USD 21.27 M

Share Price

USD 4.90

Avg Daily Volume

15,025

Change (1 day)

-3.92%

Change (1 year)

-39.58%

Change (YTD)

-8.92%

Concord Medical Services Holdings Limited EBITDA Margin for the year ending December 31, 2024: -90.02%

Concord Medical Services Holdings Limited EBITDA Margin is -90.02% for the year ending December 31, 2024, a 40.56% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Concord Medical Services Holdings Limited EBITDA Margin for the year ending December 31, 2023 was -64.04%, a -24.77% change year over year.
Concord Medical Services Holdings Limited EBITDA Margin for the year ending December 31, 2022 was -85.12%, a 13.61% change year over year.
Concord Medical Services Holdings Limited EBITDA Margin for the year ending December 31, 2021 was -74.92%, a -29.41% change year over year.
Concord Medical Services Holdings Limited EBITDA Margin for the year ending December 31, 2020 was -106.14%, a -30.93% change year over year.